IDL Diagnostics AB (FRA:80R) GF Score: 55/100 (As of Jul. 16, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:80R IDL Diagnostics AB FRA:80R
55 GF Score
Price €0.03
GF Value €0.03
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB GF Score?

IDL Diagnostics AB FRA:80R +5.79% 55 GF Score is 55 as of Jul. 16, 2026, which is 6% above its 10-year median of 52.00. GuruFocus rates FRA:80R with a GF Score™ of 55/100 and a GF Value™ of €0.03. The stock has 2 warning signs investors should review.

IDL Diagnostics AB has the GF Score of 55, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 3/10
3. Growth Rank : 9/10
4. GF Value Rank : 10/10
5. Momentum Rank : 8/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes IDL Diagnostics AB might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

IDL Diagnostics AB  (FRA:80R) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

IDL Diagnostics AB GF Score Related Terms

FRA:80R vs TMO, DHR, IDXX: GF Score Comparison

For the Diagnostics & Research subindustry, IDL Diagnostics AB's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IDL Diagnostics AB GF Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Diagnostics AB's GF Score distribution charts can be found below:

* The bar in red indicates where IDL Diagnostics AB's GF Score falls into.


FRA:80R
55GF Score
IDL Diagnostics AB FRA:80R
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 55 mean?
IDL Diagnostics AB (FRA:80R) has a GF Score of 55 as of Jul. 16, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on IDL Diagnostics AB and its competitors. This is near median its historical median of 52.00. Over the past decade, IDL Diagnostics AB's GF Score has ranged from 15.00 to 82.00.
Is IDL Diagnostics AB's GF Score too high?
IDL Diagnostics AB's current GF Score of 55 is near median its 10-year median of 52.00. Over the past 10 years, this metric has ranged from a low of 15.00 to a high of 82.00. Overall, IDL Diagnostics AB has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does IDL Diagnostics AB's GF Score compare to TMO and DHR?
IDL Diagnostics AB's GF Score of 55 can be compared against companies in the Medical Diagnostics & Research industry. Historically, IDL Diagnostics AB's own GF Score has ranged from 15.00 to 82.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Diagnostics & Research company?
A good GF Score depends on the Medical Diagnostics & Research industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on IDL Diagnostics AB and its competitors. IDL Diagnostics AB's current GF Score is 55, which is near median its own 10-year median of 52.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDL Diagnostics AB stock overvalued right now?
IDL Diagnostics AB (FRA:80R) has a current GF Score of 55. The stock's GF Value™ is €0.03, compared to a current price of €0.03 — trading 14.7% below its estimated fair value. The current GF Score is 55, which is near median its 10-year median of 52.00. IDL Diagnostics AB's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For IDL Diagnostics AB (FRA:80R), the current GF Score is 55 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDL Diagnostics AB (FRA:80R) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of €0.03 is trading 14.7% below its estimated GF Value™ of €0.03.

Key valuation signals for FRA:80R:

  • GF Score: 55 (near median its 10-year median of 52.00)
  • GF Value™: €0.03 vs. price of €0.03 (14.7% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FRA:80R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IDL Diagnostics AB Business Description

Other Exchanges IDLDX:Sweden
Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for FRA:80R

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.03
GF Value